Cost Management IssuesWhile infusion top line has been strong, the costs were not managed well, though efforts are underway to improve standardization and scaling.
Home Health Rate UpdatesThere is concern about the size of the recoupment under the home health rate updates, which could impact future acquisitions until more clarity is achieved.
Share Price MomentumShare momentum might stall in the near term due to profit taking after the significant share price increase.